In Stinging Op-Ed, West Virginia Senate Leader Bashes Drug Industry and Rejects Efforts to Politicize 340B Program

West Virginia Senate President Craig Blair (R), who also serves as the state’s lieutenant governor, told 340B Report that he’s weighing potential litigation against Stand for Us PAC, which has claimed credit for the GOP leader’s May 14 primary loss. (Photo courtesy: WV Senate.)
A key West Virginia lawmaker this week hit back against efforts to tie the 340B program to partisan politics, arguing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Draft Senate Drug Shortages Bill Sparks Stakeholder Debate over 340B Provisions

Stakeholders recently submitted feedback on a draft Senate Finance Committee drug shortages bill with 340B implications.
A draft Senate bill, which would offer bonus payments to hospitals that stockpile certain generic drugs and forgo other rebates [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Key House Hearing Intensifies Debate on 340B’s Future Amid Multiple Major Reform Efforts

Rep. Morgan Griffith (R-VA), chairman of the House Energy and Commerce Oversight and Investigations Subcommittee, speaks at a hearing on June 4, 2024.
A House oversight hearing this week added to the growing debate over the 340B program’s future as federal lawmakers continue [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

In Key Hearing, GOP Lawmakers Raise Concerns About 340B Growth and Hospital Use While Democrats Urge Caution

Sue Veer, president and CEO, Carolina Health Centers, speaks at the House Energy and Commerce Committee's Oversight and Investigations Subcommittee hearing on June 4, 2024.
340B hospitals need new transparency requirements and program eligibility rules to ensure the sustainability of the program, Republican lawmakers said [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Today’s 340B Congressional Hearing Will Include Multiple 340B Critics, Leading Hospital and Health Center Advocates

Dr. Anthony DiGiorgio, a free-market physician at UCSF who suggested last year that Congress could consider ending the 340B program, is one of four witnesses who will testify at a June 4 Congressional hearing on 340B.
A key House subcommittee oversight hearing today on the 340B program will include a witness who previously said Congress should [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

OPA to Hold June 11 Webinar on Final ADR Rule

HRSA headquarters
The Health Resources and Services Administration announced that the Office of Pharmacy Affairs will hold a June 11 webinar on the ADR final rule.
The federal office tasked with overseeing the 340B program will brief covered entities and manufacturers next week on the administrative [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

ASAP 340B-Backed Bill Would Override State Laws, Could Hurt Contract Pharmacy Agreements, Critics Warn

U.S. Capitol building at sunrise
Five congressional Democrats signed on as co-sponsors to a bill that would bar drugmaker restrictions on 340B contract pharmacy arrangements.
Some long-time 340B advocates have warned that a new federal bill based on input from an alliance of the drug [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Critic, Health Center Leader Among Witnesses at Upcoming 340B Hearing

A 340B hearing next week called by Rep. Cathy McMorris Rodgers (R-Wash.), chair of the E&C Committee, will include as witnesses a policy researcher critical of 340B and a community health center leader.
A fellow from a think tank that receives drug industry funding for its 340B work and a national leader for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Key House Oversight Subcommittee to Hold Hearing on 340B Next Tuesday

Energy and Commerce
Rep. Cathy McMorris Rogers (R-Washington) chair of the Energy & Commerce Committee, and Rep. Morgan Griffith (R-Virginia), chair of the Oversight and Investigations Subcommittee, announced a June 4 hearing on 340B.
A subcommittee of the House Energy and Commerce (E&C) Committee, which is tasked with overseeing the 340B drug discount program, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

No Adverse Findings in First HRSA Drugmaker Audit of 2024

Federal auditors recently reported no adverse findings in their first fiscal year 2024 340B audit of a pharmaceutical manufacturer.
Federal auditors recently reported no adverse findings in their first fiscal year 2024 340B audit of a pharmaceutical manufacturer. On [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live